Guardian Capital LP Pfizer Inc Transaction History

Guardian Capital LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $571,239 - $740,729	-17,582 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $8.48 Million - $9.52 Million	-229,254 Reduced 92.88%	17,582 $762,000
Q1 2019 May 15, 2019	SELL	$37.5 - $41.2 $722,812 - $794,130	-19,275 Reduced 7.24%	246,836 $10.5 Million
Q4 2018 Feb 13, 2019	SELL	$38.47 - $43.86 $549,774 - $626,803	-14,291 Reduced 5.1%	266,111 $11.6 Million
Q3 2018 Nov 13, 2018	BUY	$34.47 - $41.81 $24,232 - $29,392	703 Added 0.25%	280,402 $12.4 Million
Q2 2018 Aug 14, 2018	BUY	$32.98 - $35.16 $1.01 Million - $1.07 Million	30,561 Added 12.27%	279,699 $10.1 Million
Q1 2018 May 15, 2018	BUY	$31.91 - $37.02 $907,807 - $1.05 Million	28,449 Added 12.89%	249,138 $8.84 Million
Q4 2017 Feb 14, 2018	SELL	$33.26 - $35.29 $6,552 - $6,952	-197 Reduced 0.09%	220,689 $7.99 Million
Q3 2017 Nov 15, 2017	SELL	$31.0 - $34.15 $54,281 - $59,796	-1,751 Reduced 0.79%	220,886 $7.89 Million
Q2 2017 Aug 14, 2017	BUY	N/A	222,637	222,637 $7.48 Million

3,256

3.62B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $144B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Guardian Capital LP, based on Form 13F filings with the SEC.

Stay updated on Guardian Capital LP with notifications on news.